Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
TICK-BORNE ENCEPHALITIS VACCINATION IN THE SWISS COMMUNITY PHARMACIES IN 2018
- In: What’s new in practice? Part 2 on Tuesday, 24 September 2019, 16:20-16:30
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: BESANçON, Luc (pharmaSuisse, Switzerland)
- Co-author(s): Danielle Stegmann: pharmaSuisse, Bern-Liebefeld, Switzerland
Martine Ruggli: pharmaSuisse, Bern-Liebefeld, Switzerland
Luc Besançon: pharmaSuisse, Bern-Liebefeld, Switzerland
Fabian Vaucher: pharmaSuisse, Bern-Liebefeld, Switzerland - Abstract:
Background
Tick-borne encephalitis is a viral disease transmitted in the majority of cases by ticks (Ixodes ricinus). In 2018, 377 cases were reported to the Swiss authorities compared to less than 100 cases in 2000. Swiss authorities recommend vaccination against tick-borne encephalitis for all individuals with increased risk of exposure. Swiss
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023